Rand Capital Q2 2026: NAV $17.33, $6.9M Deployed, Dividend Maintained
RAND is trading near its 52-week low of $10 (3.8% above the low) on light trading volume (0.3× avg).
Summary
Declining investment income and a shrinking cash position mark Rand Capital's Q2 2026, offset by new deployments and a realized gain. The maintained dividend and near-52-week-low stock price highlight the tension between income stability and portfolio quality.
Key Events · Earnings and Guidance · RAND
-
Investment Income Declines 13%
Total investment income fell to $1.4 million from $1.6 million a year ago, primarily because five portfolio companies on non-accrual status reduced interest income.
-
NAV Per Share Dips to $17.33
Net asset value per share decreased from $17.57 at year-end 2025 to $17.33, reflecting unrealized depreciation and the BMP Swanson write-down.
-
$6.9M Deployed, $959K Gain Realized
The company invested $4.5 million in Feature Healthcare and $2.4 million in Termite Guy, while exiting Applied Image with a $959,000 realized gain.
-
Cash Drops to $430K, Credit Line Tapped
Cash and equivalents fell from $4.2 million to $430,000; $5.1 million drawn on the $17.5 million credit line, leaving $12.4 million available.
Analysis · RAND · Unknown
Q2 2026 results from Rand Capital reveal a 13% decline in investment income to $1.4 million, pressured by non-accruals. NAV per share slipped to $17.33 from $17.57 at year-end. While the company deployed $6.9 million into two new portfolio companies and realized a $959,000 gain on an exit, a $2.5 million write-down on BMP Swanson and a sharp drop in cash to $430,000 raise liquidity concerns. The $0.29 quarterly dividend was maintained, but the stock trades near its 52-week low, reflecting market skepticism about the BDC's ability to sustain payouts amid portfolio stress.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.6% of the 1742 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RAND was trading at $10.38 on NASDAQ in the Unknown sector, with a market capitalization of approximately $30.8M. The 52-week trading range was $10.00 to $20.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.